Tannir NM - Search Results

1

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial.

Motzer RJ, Escudier B, McDermott DF, Arén Frontera O, Melichar B, Powles T, Donskov F, Plimack ER, Barthélémy P, Hammers HJ, George S, Grünwald V, Porta C, Neiman V, Ravaud A, Choueiri TK, Rini BI, Salman P, Kollmannsberger CK, Tykodi SS, Grimm MO, Gurney H, Leibowitz-Amit R, Geertsen PF, Amin A, Tomita Y, McHenry MB, Saggi SS, Tannir NM. Motzer RJ, et al. Among authors: tannir nm. J Immunother Cancer. 2020 Jul;8(2):e000891. doi: 10.1136/jitc-2020-000891. J Immunother Cancer. 2020. PMID: 32661118 Free PMC article. Clinical Trial.

2

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes.

Rodney A, Dieringer P, Mathew P, Jonasch E, Tannir N, Pagliaro LC. Rodney A, et al. Cancer. 2006 May 15;106(10):2143-7. doi: 10.1002/cncr.21894. Cancer. 2006. PMID: 16598751 Free article. Clinical Trial.

3

Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.

Tannir N, Jonasch E, Pagliaro LC, Mathew P, Siefker-Radtke A, Rhines L, Lin P, Tibbs R, Do KA, Lin SH, Tu SM. Tannir N, et al. Cancer. 2006 Aug 1;107(3):497-505. doi: 10.1002/cncr.22038. Cancer. 2006. PMID: 16795067 Free article. Clinical Trial.

4

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Spiess PE, et al. Among authors: tannir nm. Cancer. 2006 Oct 1;107(7):1503-10. doi: 10.1002/cncr.22181. Cancer. 2006. PMID: 16944534 Free article.

5

Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.

Tannir NM, Cohen L, Wang X, Thall P, Mathew PF, Jonasch E, Siefker-Radtke A, Pagliaro LC, Ng CS, Logothetis C. Tannir NM, et al. Cancer. 2006 Nov 1;107(9):2254-61. doi: 10.1002/cncr.22253. Cancer. 2006. PMID: 17029276 Free article. Clinical Trial.

6

Patient survival after surgery for osseous metastases from renal cell carcinoma.

Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW. Lin PP, et al. Among authors: tannir nm. J Bone Joint Surg Am. 2007 Aug;89(8):1794-801. doi: 10.2106/JBJS.F.00603. J Bone Joint Surg Am. 2007. PMID: 17671020

7

Treatment outcomes of small cell carcinoma of the prostate: a single-center study.

Spiess PE, Pettaway CA, Vakar-Lopez F, Kassouf W, Wang X, Busby JE, Do KA, Davuluri R, Tannir NM. Spiess PE, et al. Among authors: tannir nm. Cancer. 2007 Oct 15;110(8):1729-37. doi: 10.1002/cncr.22971. Cancer. 2007. PMID: 17786954 Free article. Clinical Trial.

8

Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?

Spiess PE, Tannir NM, Tu SM, Brown GA, Liu P, Kamat AM, Wood CG, Evans JG, Pisters LL. Spiess PE, et al. Among authors: tannir nm. Cancer. 2007 Dec 15;110(12):2700-8. doi: 10.1002/cncr.23104. Cancer. 2007. PMID: 17948916 Free article.

9

Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings.

Jonasch E, Wood C, Tamboli P, Pagliaro LC, Tu SM, Kim J, Srivastava P, Perez C, Isakov L, Tannir N. Jonasch E, et al. Br J Cancer. 2008 Apr 22;98(8):1336-41. doi: 10.1038/sj.bjc.6604266. Epub 2008 Mar 25. Br J Cancer. 2008. PMID: 18362942 Free PMC article.

10

Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor.

Khakoo AY, Kassiotis CM, Tannir N, Plana JC, Halushka M, Bickford C, Trent J 2nd, Champion JC, Durand JB, Lenihan DJ. Khakoo AY, et al. Cancer. 2008 Jun;112(11):2500-8. doi: 10.1002/cncr.23460. Cancer. 2008. PMID: 18386829 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page